CRO with innovative proprietary services for efficient development of new therapeutics. ROI of 6M€ after 5 years for 1.4M€ invested.
Cardinal Systems is a mid-size full clinical CRO that includes stand-alone methodological/IT business, such as centralized randomization. The company has grown with the needs of biotechs, and is specialized in adaptive design and complex tailored project management. We have strong competitive advantages (and barriers) for a leading position in the field of adaptive trials (I/II or II/III).